Pulsus Expands to Europe, inks deal with 25 Scientific and Healthcare societies

Food and Healthcare Press Releases Thursday April 26, 2018 16:41
LONDON--26 Apr--PRNewswire/InfoQuest
Dr. Srinubabu Gedela, CEO of Pulsus and Omics International, announced 2018 Pulsus European expansion

Realizing the great potentialities of the European countries, including Germany, Spain, Netherlands, France and Portugal, Pulsus Group announced the expansion of its scientific research and publication activities to Europe, apart from the Asia Pacific, Middle East, and America. To establish its operations into these new markets, Pulsus revealed a mutual partnership agreement with 25 scientific and healthcare societies.

The latest addendum to this initiative is support from the European region, which includes Polish Society of Orthopaedics and Traumatology, European Biotechnology Thematic Network Association, World Federation of Pediatric Intensive and Critical Care Societies, International Society for Ceramics in Medicine, Thalassaemia International Federation and World Association of Integrated Medicine and Switch Biotech Association.

Making the announcement,   Dr. Srinubabu Gedela , CEO of PULSUS, said: "By such partnership with societies,   Pulsus Group is inclined to increase scientific compliance by creating networks, coordinating with peers and mutual cooperation."

With the support from industry and academia, Pulsus and its subsidiaries Omics international , meetings international and conference series will be able to schedule 3,000 global annual events in 40 countries for 2018. These conferences attract 50 million+ online visitors, 25000+ online unique visitors per conference and 75000+ page views for every individual conference would help in quantifying every presenter's research and biography, visibility to the online communities and get recognized worldwide.

Interestingly,   Pulsus meetings provide a high-class opportunity to the nurse practitioners to publish their abstract and full-length articles in the respective journals with specific DOI Number provided by CrossRef. Speakers' profiles displayed on the conference websites give a special recognition to the healthcare practitioners.

The nursing conference presentations enhance the nursing professionals' global viewership on pioneering platforms like Facebook, LinkedIn, Twitter, YouTube, Vimeo and other social media platforms. With attendees drawn from around the globe, researchers, scholars, students and the industry could benefit from demonstrations, workshops, symposiums, and exhibitions that facilitate information exchange, meeting the current and potential practitioners, and product promotion. Pulsus Meetings also provide CME, CPD, CE and CNE credit essential to maintain competency.

About Pulsus Group: Pulsus Groups is a health informatics and healthcare services company. Headquartered in Singapore, PULSUS employs 5000+ employees, across its offices in Pulsus-London , Pulsus-Chennai , Pulsus-Gurgaon and Pulsus-Hyderabad .

Logo - https://mma.prnewswire.com/media/544592/PULSUS_Logo.jpg

Latest Press Release

WCG (WIRB-Copernicus Group) Clinical Services Division Opens Office in Japan

WCG(TM) (WIRB-Copernicus Group(R)) Clinical Services Division, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the opening of the company's new office in Tokyo, Japan....

Head-to-Head Trial Shows Refixia(R) Achieves Greater Total Factor IX Exposure in People With Haemophilia B Than Recombinant Factor IX-Fc Fusion Protein

Adults with haemophilia B who received a single dose Refixia(R) (nonacog beta pegol; N9-GP) achieved greater total factor IX exposure than those treated with rFIXFc (recombinant factor IX-Fc fusion protein). The head-to-head paradigm7 trial also observed...

NovoEight(R) Maintains Potency When Stored at 40?C Offering People With Haemophilia A Increased Flexibility in Their Daily Lives

A new long term stability study has shown that haemophilia A treatment NovoEight(R) (turoctocog alfa) remains potent after three months exposure to temperatures of 40ºC.[1] The results were presented today at the WFH 2018 World Congress in Glasgow,...

The Mall Shopping Center and Government Savings Bank Co-host The Mall Health Beauty Expo 2018

The Mall Shopping Center, Government Savings Bank, leading hospitals and health institutions are co-hosting an annual grand event, "The Mall Health & Beauty Expo 2018" on June 28 – July 4, 2018 at the Grand Hall, G Floor, The Mall Bangkapi....

Merck Data at ASCO 2018 to Showcase Progress and Further Optionality of Oncology Pipeline

ASCO Abstract # ERBITUX(R) (cetuximab): 3521, 3534, e15711; avelumab: 9507, 9537, 9090, 9008, 8563, 3057, 4544, e21531, e13603, e18932, e21623, e21620, e21544; tepotinib (c-Met kinase inhibitor): 9082, 9016; M6620 (ATR inhibitor): 2549, e21048; M3814...

Related Topics